Large-scale analysis of lysine SUMOylation by SUMO remnant immunoaffinity profiling

Nature Communications

Volumn 5, Issue , 2014, Pages

  Lamoliatte, Frédéric ^a,b   Caron, Danielle ^a   Durette, Chantal ^a   Mahrouche, Louiza ^a,b   Maroui, Mohamed Ali ^c   Caron Lizotte, Olivier ^a   Bonneil, Eric ^a   Chelbi Alix, Mounira K ^c   Thibault, Pierre ^a,b  

^a INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 2; ACTIVATING TRANSCRIPTION FACTOR 4; BLOOM SYNDROME HELICASE; CDC73 PROTEIN; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 1; CYCLIN DEPENDENT KINASE 4; LYSINE; MONOCLONAL ANTIBODY; MYC PROTEIN; PROMYELOCYTIC LEUKEMIA PROTEIN; PROTEASOME; PROTEOME; SUMO PROTEIN; TRANSCRIPTION FACTOR MAF; TUMOR SUPPRESSOR PROTEIN; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG; CDC73 PROTEIN, HUMAN; PEPTIDE;

AMINO ACID; APOPTOSIS; CYTOPLASM; ENZYME ACTIVITY; IMMUNE SYSTEM; INHIBITION; PEPTIDE; PROTEIN; TUMOR;

ANTIBODY AFFINITY; ARTICLE; CELL DEATH; CELL FRACTIONATION; CELL NUCLEUS INCLUSION BODY; CELL SURVIVAL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CROSS REACTION; CYTOPLASM; DNA REPAIR; ENZYME INHIBITION; ESCHERICHIA COLI; GENE CONTROL; HEK293 CELL LINE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IN VITRO STUDY; LARGE SCALE PRODUCTION; NONHUMAN; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEOMICS; QUANTITATIVE ANALYSIS; SUMOYLATION; TRANSCRIPTION ELONGATION; AFFINITY CHROMATOGRAPHY; ANIMAL; HYBRIDOMA; IMMUNOLOGY; MASS FRAGMENTOGRAPHY; METABOLISM; RABBIT;

ANIMALS; ANTIBODIES, MONOCLONAL; CHROMATOGRAPHY, AFFINITY; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HEK293 CELLS; HUMANS; HYBRIDOMAS; LYSINE; PEPTIDES; PROTEOME; RABBITS; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS; SUMOYLATION; TUMOR SUPPRESSOR PROTEINS;

EID: 84925341263     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms6409     Document Type: Article

References (43)

1. Geoffroy, M. C. & Hay, R. T. An additional role for SUMO in ubiquitin-mediated proteolysis. Nat. Rev. Mol. Cell. Biol. 10, 564-568 (2009).
2. Johnson, E. S. Protein modification by SUMO. Annu. Rev. Biochem. 73, 355-382 (2004).
3. Matunis, M. J., Coutavas, E. & Blobel, G. A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex. J. Cell Biol. 135, 1457-1470 (1996).
4. Melchior, F. SUMO-nonclassical ubiquitin. Annu. Rev. Cell. Dev. Biol. 16, 591-626 (2000).
5. Seeler, J. S. & Dejean, A. Nuclear and unclear functions of SUMO. Nat. Rev. Mol. Cell. Biol. 4, 690-699 (2003).
6. Saitoh, H. & Hinchey, J. Functional heterogeneity of small ubiquitin-related protein modifiers SUMO-1 versus SUMO-2/3. J. Biol. Chem. 275, 6252-6258 (2000).
7. Mukhopadhyay, D. & Dasso, M. Modification in reverse: the SUMO proteases. Trends Biochem. Sci. 32, 286-295 (2007).
8. Fuhs, S. R. & Insel, P. A. Caveolin-3 undergoes SUMOylation by the SUMO E3 ligase PIASy: sumoylation affects G-protein-coupled receptor desensitization. J. Biol. Chem. 286, 14830-14841 (2011).
9. Tatham, M. H. et al. RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation. Nat. Cell Biol. 10, 538-546 (2008).
10. Tatham, M. H. et al. Polymeric chains of SUMO-2 and SUMO-3 are conjugated to protein substrates by SAE1/SAE2 and Ubc9. J. Biol. Chem. 276, 35368-35374 (2001).
11. Galisson, F. et al. A novel proteomics approach to identify SUMOylated proteins and their modification sites in human cells. Mol. Cell Proteomics 10, M110 004796 (2011).
12. Matic, I. et al. In vivo identification of human small ubiquitin-like modifier polymerization sites by high accuracy mass spectrometry and an in vitro to in vivo strategy. Mol. Cell Proteomics 7, 132-144 (2008).
13. Vertegaal, A. C. et al. A proteomic study of SUMO-2 target proteins. J. Biol. Chem. 279, 33791-33798 (2004).
14. Denison, C. et al. A proteomic strategy for gaining insights into protein sumoylation in yeast. Mol. Cell Proteomics 4, 246-254 (2005).
15. Hannich, J. T. et al. Defining the SUMO-modified proteome by multiple approaches in Saccharomyces cerevisiae. J. Biol. Chem. 280, 4102-4110 (2005).
16. Panse, V. G., Hardeland, U., Werner, T., Kuster, B. & Hurt, E. A proteome-wide approach identifies sumoylated substrate proteins in yeast. J. Biol. Chem. 279, 41346-41351 (2004).
17. Nie, M., Xie, Y., Loo, J. A. & Courey, A. J. Genetic and proteomic evidence for roles of Drosophila SUMO in cell cycle control, Ras signaling, and early pattern formation. PLoS ONE 4, e5905 (2009).
18. Miller, M. J., Barrett-Wilt, G. A., Hua, Z. & Vierstra, R. D. Proteomic analyses identify a diverse array of nuclear processes affected by small ubiquitin-like modifier conjugation in Arabidopsis. Proc. Natl Acad. Sci. USA 107, 16512-16517 (2010).
19. Golebiowski, F. et al. System-wide changes to SUMO modifications in response to heat shock. Sci. Signal. 2, ra24 (2009).
20. Matafora, V., D'Amato, A., Mori, S., Blasi, F. & Bachi, A. Proteomics analysis of nucleolar SUMO-1 target proteins upon proteasome inhibition. Mol. Cell. Proteomics 8, 2243-2255 (2009).
21. Vertegaal, A. C. et al. Distinct and overlapping sets of SUMO-1 and SUMO-2 target proteins revealed by quantitative proteomics. Mol. Cell. Proteomics 5, 2298-2310 (2006).
22. Matic, I. et al. Site-specific identification of SUMO-2 targets in cells reveals an inverted SUMOylation motif and a hydrophobic cluster SUMOylation motif. Mol. Cell 39, 641-652 (2010).
23. Yang, W. et al. Analysis of oxygen/glucose-deprivation-induced changes in SUMO3 conjugation using SILAC-based quantitative proteomics. J. Proteome Res. 11, 1108-1117 (2012).
24. Zhou, W., Ryan, J. J. & Zhou, H. Global analyses of sumoylated proteins in Saccharomyces cerevisiae. Induction of protein sumoylation by cellular stresses. J. Biol. Chem. 279, 32262-32268 (2004).
25. Bruderer, R. et al. Purification and identification of endogenous polySUMO conjugates. EMBO Rep. 12, 142-148 (2011).
26. Becker, J. et al. Detecting endogenous SUMO targets in mammalian cells and tissues. Nat. Struct. Mol. Biol. 20, 525-531 (2013).
27. Pedrioli, P. G. et al. Automated identification of SUMOylation sites using mass spectrometry and SUMmOn pattern recognition software. Nat. Methods 3, 533-539 (2006).
28. Hsiao, H. H., Meulmeester, E., Frank, B. T., Melchior, F. & Urlaub, H. 'ChopNSpice,' a mass spectrometric approach that allows identification of endogenous small ubiquitin-like modifier-conjugated peptides. Mol. Cell. Proteomics 8, 2664-2675 (2009).
29. Rozenblatt-Rosen, O. et al. The parafibromin tumor suppressor protein is part of a human Paf1 complex. Mol. Cell. Biol. 25, 612-620 (2005).
30. Lamoliatte, F. et al. Targeted identification of SUMOylation sites in human proteins using affinity enrichment and paralog-specific reporter ions. Mol. Cell. Proteomics 12, 2536-2550 (2013).
31. Schimmel, J. et al. The ubiquitin-proteasome system is a key component of the SUMO-2/3 cycle. Mol. Cell. Proteomics 7, 2107-2122 (2008).
32. Schwartz, D. & Gygi, S. P. An iterative statistical approach to the identification of protein phosphorylation motifs from large-scale data sets. Nat. Biotechnol. 23, 1391-1398 (2005).
33. Yang, S. H., Galanis, A., Witty, J. & Sharrocks, A. D. An extended consensus motif enhances the specificity of substrate modification by SUMO. EMBO. J. 25, 5083-5093 (2006).
34. Hietakangas, V. et al. PDSM, a motif for phosphorylation-dependent SUMO modification. Proc. Natl Acad. Sci. USA 103, 45-50 (2006).
35. Tatham, M. H., Matic, I., Mann, M. & Hay, R. T. Comparative proteomic analysis identifies a role for SUMO in protein quality control. Sci. Signal. 4, rs4 (2011).
36. Takahashi, A. et al. SHP2 tyrosine phosphatase converts parafibromin/Cdc73 from a tumor suppressor to an oncogenic driver. Mol. Cell 43, 45-56 (2011).
37. Tammsalu, T. et al. Proteome-wide identification of SUMO2 modification sites. Sci. Signal. 7, rs2 (2014).
38. Udeshi, N. D. et al. Refined preparation and use of anti-diglycine remnant (K-epsilon-GG) antibody enables routine quantification of 10,000 s of ubiquitination sites in single proteomics experiments. Mol. Cell. Proteomics 12, 825-831 (2013).
39. Rodriguez, J. A. Interplay between nuclear transport and ubiquitin/SUMO modifications in the regulation of cancer-related proteins. Semin. Cancer Biol. 27C, 11-19 (2014).
40. Truong, K., Lee, T. D., Li, B. & Chen, Y. Sumoylation of SAE2 C terminus regulates SAE nuclear localization. J. Biol. Chem. 287, 42611-42619 (2012).
41. Maroui, M. A. et al. Requirement of PML SUMO interacting motif for RNF4- or arsenic trioxide-induced degradation of nuclear PML isoforms. PLoS ONE 7, e44949 (2012).
42. Dantuma, N. P., Groothuis, T. A., Salomons, F. A. & Neefjes, J. A dynamic ubiquitin equilibrium couples proteasomal activity to chromatin remodeling. J. Cell Biol. 173, 19-26 (2006).
43. Marcantonio, M., Trost, M., Courcelles, M., Desjardins, M. & Thibault, P. Combined enzymatic and data mining approaches for comprehensive phosphoproteome analyses: application to cell signaling events of interferon-gamma-stimulated macrophages. Mol. Cell. Proteomics 7, 645-660 (2008).